[1]
Shrestha, S. et al. 2021. Adverse events following the first dose of ChAdOx1 nCoV-19 (COVISHIELD) vaccine in the first phase of vaccine roll out in Nepal. Journal of Patan Academy of Health Sciences. 8, 1 (May 2021), 9–17.